Avience Biomedicals SME IPO GMP Today
ListedUpdated 23 June 2026, 5:30 PM IST· NSE SME· Listing 25 Jun 2026
Avience Biomedicals SME IPO opens on 18 June 2026. Avience Biomedicals SME IPO GMP is Rs 145.00 today. Listing price estimate is Rs 353.00 (issue price Rs 208.00). Listing gain estimate: 69.71%.
Avience Biomedicals SME IPO GMP Day Wise
Daily grey market premium, estimated listing price, and profit per lot
GMP for Avience Biomedicals SME started at Rs 0 on 13 June 2026 and stood at Rs 83 on 23 June 2026. The sharpest single-day jump was from Rs 0 on 14 Jun 2026 to Rs 70 on 15 Jun 2026. The upward move through the subscription window usually reflects building demand across investor categories rather than a one-day spike.
| Date | Issue Price | GMP | Listing Price | Est. Profit |
|---|---|---|---|---|
| 23 Jun 2026Today | Rs 208.00 | Rs 83.00 | Rs 291.00 (+39.90%) | Rs 99,600.00 |
| 22 Jun 2026 | Rs 208.00 | Rs 72.00 | Rs 280.00 (+34.62%) | Rs 86,400.00 |
| 21 Jun 2026 | Rs 208.00 | Rs 70.00 | Rs 278.00 (+33.65%) | Rs 84,000.00 |
| 20 Jun 2026 | Rs 208.00 | Rs 85.00 | Rs 293.00 (+40.87%) | Rs 1,02,000.00 |
| 19 Jun 2026 | Rs 208.00 | Rs 85.00 | Rs 293.00 (+40.87%) | Rs 1,02,000.00 |
| 18 Jun 2026 | Rs 208.00 | Rs 85.00 | Rs 293.00 (+40.87%) | Rs 1,02,000.00 |
| 17 Jun 2026 | Rs 208.00 | Rs 75.00 | Rs 283.00 (+36.06%) | Rs 90,000.00 |
| 16 Jun 2026 | Rs 208.00 | Rs 63.00 | Rs 271.00 (+30.29%) | Rs 75,600.00 |
| 15 Jun 2026 | Rs 208.00 | Rs 70.00 | Rs 278.00 (+33.65%) | Rs 84,000.00 |
| 14 Jun 2026 | Rs 208.00 | Rs 0.00 | Rs 208.00 (+0.00%) | Rs 0.00 |
| 13 Jun 2026 | Rs 208.00 | Rs 0.00 | Rs 208.00 (+0.00%) | Rs 0.00 |
Avience Biomedicals SME IPO Listing Price
Estimated from today’s GMP
Based on today's GMP, Avience Biomedicals SME IPO listing price estimate is Rs 353.00 per share (issue price Rs 208.00 + GMP Rs 145.00).
Actual listing price will be known on 25 June 2026 when the stock lists on NSE/BSE.
Avience Biomedicals SME IPO Listing Gain
Estimated profit per lot from grey market premium
Lot size: 600 shares (min. 2 lots for SME)
GMP today: Rs 145.00
Estimated listing gain per lot: Rs 145.00 × 1200 = Rs 1,74,000.00
A GMP of around 69.7% is a strong positive signal from the grey market. Investors are pricing in a meaningful listing premium over the issue price.
GMP has moved up over the tracked period. Steady increases through the subscription window are usually a stronger signal than a single-day spike.
GMP is unofficial. Listing gain can differ on listing day.
Avience Biomedicals SME IPO Subscription Status
GMP and subscription numbers often move together. When institutional and HNI demand is strong, grey market participants usually price in a higher premium. Current overall subscription for Avience Biomedicals SME is 385.4x. Compare this with the GMP trend to see if demand aligns. The GMP move around 15 Jun 2026 may reflect how the market reacted once the subscription window activity picked up after 18 Jun 2026.
See live figures on the Avience Biomedicals SME IPO Subscription Status page.
Avience Biomedicals SME IPO Details
| Field | Value |
|---|---|
| Price Band | ₹196.0 - ₹208.0 |
| Issue Size | ₹30.24 Cr |
| Lot Size | 600 shares |
| IPO Type | NSE SME |
| Open Date | 18 Jun 2026 |
| Close Date | 22 Jun 2026 |
| Listing Date | 25 Jun 2026 |
| Subscription | 385.4x |
Avience Biomedicals SME IPO full details (financials, peers, review).
About Avience Biomedicals SME
Avience Biomedicals Limited, incorporated in June 2024, is an ISO-certified healthcare and biotechnology solutions company. The enterprise specializes in manufacturing, supplying, and exporting high-precision molecular diagnostic formulations, in-vitro diagnostics (IVD) rapid test kits, serology products, and automated biochemistry and hematology analyzers. Operating entirely on business-to-business (B2B) and business-to-government (B2G) frameworks, Avience provides cost-effective diagnostics to premier hospital networks, pathology labs, and research institutions. Its manufacturing footprint is centered in Noida, Uttar Pradesh, with its technical pipelines expanding to cover emergency critical care lines, including oxygen concentrators and viral transport solutions.
Avience Biomedicals SME IPO GMP FAQs
What is Avience Biomedicals SME IPO GMP today?
Avience Biomedicals SME IPO GMP is ₹145 as of 18 October 2026, 6:01 PM IST. At issue price ₹208, that is +69.71% expected listing gain in the grey market.
What is Avience Biomedicals SME IPO grey market premium (GMP)?
The grey market premium (GMP) for Avience Biomedicals SME IPO is ₹145 today. GMP is the unofficial premium traders pay above the issue price of ₹208 before listing on NSE/BSE.
What is Avience Biomedicals SME IPO expected returns?
Avience Biomedicals SME IPO expected returns based on today's GMP are +69.71% over the issue price of ₹208. Estimated listing price is ₹353 per share. Actual listing gain on 25 June 2026 may differ.
What is the estimated listing price of Avience Biomedicals SME IPO?
Based on today's GMP, Avience Biomedicals SME IPO estimated listing price is ₹353 per share (issue price ₹208 + GMP ₹145). The actual listing price will be set on 25 June 2026 when trading starts.
What is the expected profit per lot in Avience Biomedicals SME IPO?
At GMP of ₹145 and lot size of 600 shares (minimum 2 lots for SME), estimated grey market profit is ₹1,74,000 (2 lot × 600 shares × ₹145). This is unofficial and not guaranteed on listing day.
Will Avience Biomedicals SME IPO list at GMP price?
Avience Biomedicals SME IPO may list around ₹353 based on current GMP of ₹145, but listing at exact grey market price is not guaranteed. GMP is unofficial. On 25 June 2026, the opening price depends on market sentiment, final subscription, and index levels.
What is Avience Biomedicals SME IPO issue price and lot size?
Avience Biomedicals SME IPO issue price is ₹208 per share (price band ₹196.0 - ₹208.0). Lot size is 600 shares. Minimum application is 2 lots for SME.
When is Avience Biomedicals SME IPO listing date?
Avience Biomedicals SME IPO is expected to list on 25 June 2026 on NSE and BSE. GMP can still move until listing day.
What is Avience Biomedicals SME IPO GMP high and low?
Avience Biomedicals SME IPO GMP made a high of ₹85 on 20 Jun 2026 and a low of ₹0 on 14 Jun 2026 in tracked grey market data.
Can Avience Biomedicals SME IPO GMP change after subscription closes?
Yes. Avience Biomedicals SME IPO closed on 22 June 2026. GMP often moves until listing (25 June 2026) based on allotment buzz, market mood, and news. Keep this page handy for the latest figure.
What is Avience Biomedicals SME IPO subscription status?
Live category-wise subscription for Avience Biomedicals SME IPO is on the Avience Biomedicals SME IPO Subscription Status page on IPOwiz, including QIB, NII, and retail figures.
How to check Avience Biomedicals SME IPO allotment status?
You can check Avience Biomedicals SME IPO allotment with your PAN on the Avience Biomedicals SME IPO Allotment Status page, the registrar site, BSE, or the IPOwiz App.
Sources
We match Avience Biomedicals SME IPO numbers with official sources. For final dates and allotment results, double-check the registrar or exchange.
- SEBIRules for IPO allotment and disclosures in India
- NSEExchange notices, bidding data, and listing updates
- BSEExchange notices and IPO allotment check tools
- RHP / Offer DocumentCheck the company RHP on NSE/BSE or the IPO detail page
- IPO RegistrarRegistrar details are on the allotment page for this IPO
Also read our Editorial Policy, How GMP is calculated, How allotment chances work, and IPO fund allocation.
Reviewed by
Dinesh Agrawal · Lead IPO Analyst
15+ years in Indian markets and IPO research. He reviews GMP figures before they go live.